Virus News and Research

Latest Virus News and Research

A safer and more affordable polio vaccine could soon be a reality

A more affordable, lower-risk polio vaccine is on the horizon, research led by the University of Leeds has found.

11 Mar 2025

Combination of Epstein-Barr virus antibodies and genes linked to increased risk of MS

In multiple sclerosis (MS), antibodies to the common Epstein-Barr virus can accidentally attack a protein in the brain and spinal cord. New research shows that the combination of certain viral antibodies and genetic risk factors can be linked to a greatly increased risk of MS.

10 Mar 2025

Many parents uncertain about bird flu information and risks, poll suggests

With soaring egg prices and ongoing bird flu headlines, many parents are uncertain about the risks and facts surrounding the virus, a national poll suggests.

10 Mar 2025

Canary in the coalmine: Study warns 21 million children missed measles shots in 2022

Researchers found that 21 million children missed measles vaccination in 2022, far exceeding those missing other vaccines, and 96% were in low- and middle-income countries. The study urges adding measles vaccination rates to global definitions of under-immunized children to better prevent deadly outbreaks.

10 Mar 2025

How falling measles vaccination rates put millions of children at risk

Two-dose measles vaccination coverage has fallen by 3.7% globally since 2019, leaving most WHO regions off track to meet Immunization Agenda 2030 targets. The study highlights a worrying rise in zero-dose children, especially in Africa, threatening global herd immunity against measles.

10 Mar 2025

Herpes infection through the nose can lead to anxiety, motor impairment and cognitive deficits

Herpes simplex virus-1 (HSV-1) is commonly known for causing blisters and sores. But in some cases, the virus can migrate to the eye or nervous system, causing severe, chronic symptoms.

10 Mar 2025

Next-generation, inhaled COVID-19 vaccine enters phase-2 clinical trial

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.

10 Mar 2025

Many individuals with Niemann-Pick disease lack neutralizing antibodies against AAV2 or AAV9

A new study in the peer-reviewed journal Human Gene Therapy showed that more than half of individuals with Niemann-Pick disease, type C1 (NPC1) who were tested lacked neutralizing antibodies against either adeno-associated virus (AAV) 2 or AAV9.

10 Mar 2025

MRNA vaccines, once a Trump boast, now face attacks from some in GOP

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.

10 Mar 2025

WHO and KSRelief commit to expanded health initiatives at Riyadh Forum

The Riyadh International Humanitarian Forum on 24-25 February 2025 brought together global partners from the humanitarian sector to discuss urgent health and humanitarian issues.

8 Mar 2025

New sensor offers rapid detection of airborne bird flu virus

Recent outbreaks of highly pathogenic avian influenza (also known as bird flu) have created a need for rapid and sensitive detection methods to mitigate its spread.

7 Mar 2025

Eradivir begins Phase 2 challenge study for antiviral therapeutic EV25

Eradivir, a clinical-stage small molecule immunotherapy biotech company, announced it has begun a Phase 2 challenge study with its antiviral therapeutic, EV25. The study will provide safety and efficacy data gathered from otherwise healthy participants infected with influenza then later treated with EV25.

7 Mar 2025

Incarcerated individuals face unique health risks during wildfires

When a wildfire approaches a prison and an evacuation warning is issued, what are the health risks that incarcerated people face when officials decide to not evacuate?

7 Mar 2025

Marty Makary, often wrong as pandemic critic, is poised to lead the FDA he railed against

Panelists at a covid conference last fall were asked to voice their regrets — policies they had supported during the pandemic but had come to see as misguided. Covid contact tracing, one said. Closing schools, another said. Vaccine mandates, a third said.

7 Mar 2025

Long-acting HIV injections show success in patients with struggles to take daily pills

UCSF researchers are the first to demonstrate that the approach works for the patients who need it the most.

6 Mar 2025

Scientists discover new strategy to fight back against norovirus

Scientists at The University of Texas at Austin, in collaboration with researchers from the University of North Carolina at Chapel Hill and the National Institutes of Health, have discovered a strategy to fight back against norovirus, a leading cause of gastroenteritis worldwide.

6 Mar 2025

New antibody pair could defeat all SARS-CoV-2 variants

A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2 variants. More research is needed, but the approach could help in the development of treatments to keep pace with evolving viruses.

6 Mar 2025

Study shows benefits of GLP-1 drugs for kidney transplant recipients with type 2 diabetes

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.

5 Mar 2025

Iron dysregulation linked to long COVID development

Problems with iron levels in the blood and the body's ability to regulate this important nutrient as a result of SARS-CoV-2 infection could be a key trigger for long COVID, new research has discovered.

5 Mar 2025

HPV more common in men than women and linked to rising cancer rates

While the human papillomavirus (HPV) is most associated with cervical cancer risk and women, a new survey commissioned by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) shows that the majority of people are unaware that the virus is actually more common among men than women and is associated with rising rates of other cancers that directly impact men.

4 Mar 2025

Virus News and Research

Latest Virus News and Research

A safer and more affordable polio vaccine could soon be a reality

Combination of Epstein-Barr virus antibodies and genes linked to increased risk of MS

Many parents uncertain about bird flu information and risks, poll suggests

Canary in the coalmine: Study warns 21 million children missed measles shots in 2022

How falling measles vaccination rates put millions of children at risk

Herpes infection through the nose can lead to anxiety, motor impairment and cognitive deficits

Next-generation, inhaled COVID-19 vaccine enters phase-2 clinical trial

Many individuals with Niemann-Pick disease lack neutralizing antibodies against AAV2 or AAV9

MRNA vaccines, once a Trump boast, now face attacks from some in GOP

WHO and KSRelief commit to expanded health initiatives at Riyadh Forum

New sensor offers rapid detection of airborne bird flu virus

Eradivir begins Phase 2 challenge study for antiviral therapeutic EV25

Incarcerated individuals face unique health risks during wildfires

Marty Makary, often wrong as pandemic critic, is poised to lead the FDA he railed against

Long-acting HIV injections show success in patients with struggles to take daily pills

Scientists discover new strategy to fight back against norovirus

New antibody pair could defeat all SARS-CoV-2 variants

Study shows benefits of GLP-1 drugs for kidney transplant recipients with type 2 diabetes

Iron dysregulation linked to long COVID development

HPV more common in men than women and linked to rising cancer rates

A new way of characterising biomolecules eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in